Evaxion Biotech A/S, a clinical-stage biotech firm listed on Nasdaq under the ticker EVAX, is currently navigating a challenging landscape as it appeals a delisting determination from Nasdaq. This stems from non-compliance with the minimum stockholder equity requirement of $2.5 million stipulated
In an era where electric vehicles (EVs) are becoming the vanguard of the automotive industry, Volkswagen has taken a notable step by investing $5.8 billion in Rivian. This strategic partnership, formulated under their joint venture Rivian and VW Group Technology LLC, exemplifies a strong vote of
Shares of Amgen edged up in premarket trading after the firm's announcement that its experimental obesity drug, MariTide, does not negatively impact bone mineral density. This comes following a more than 7% plunge in stock due to a report by Cantor Fitzgerald analysts, which had cited data
In the world of high finance, the recent acquisition of Credit Suisse by UBS has stirred significant regulatory waters, mainly due to concerns over Russian clients tied to the ailing bank Credit Suisse. The U.S. Office of Foreign Assets Control (OFAC), a globally recognized authority on sanctions
Alfa Laval is making significant strides in the biofuel industry, particularly in sustainable aviation fuel (SAF) production, underscoring the company’s pledge to innovation and sustainability. Recently, the firm secured two substantial contracts worth a collective 350 million SEK to provide a
The EU has made a landmark move to bolster its cyber defenses in the energy domain by enacting the network code on cybersecurity, designated as delegated act C/2024/1383, for the electricity sector. This first-of-its-kind regulation is set to significantly boost the resilience of key power
